Domains targeting keyword immunotherapy
Keyword immunotherapy was used in the provided list of websites.
Number of websites/domains displayed: 70
Results found: 70
Websites discovered:
Cancer treatments chemotherapy radiotherapy immunotherapy hormonetherapy abirateronehttp://pageoverview.com/website-report/cancernet.co.uk
Oncologist produced information about cancer and its treatments, emphasising evidence based lifestyle advice and resources to help cope with adverse effects and reduce the risks of relpase/> <meta name=
- Expected expiration: February 20th in 2019
- Creation date: February 20th in 1999
- Renew date: February 10th in 2018
- Adsense ID: pub-1737379948197858
Vaccinogen Treating Colon Cancer with OncoVAX Immunotherapyhttp://pageoverview.com/website-report/vaccinogeninc.com
Vaccinogen is a biotechnology company that produces personalized vaccines which use a patient's immune system to fight cancer.
- Expected expiration: November 6th in 2017
- Creation date: November 6th in 2007
- Renew date: March 2nd in 2017
- Google Analytics: 3030899-1
Proleukin®(aldesleukin)Immunotherapy for mM and mRCChttp://pageoverview.com/website-report/proleukin.com
Landing page for Proleukin® (aldesleukin), the immunotherapy treatment proven to offer a chance at cancer freedom beyond 10 years
- Expected expiration: October 4th in 2017
- Creation date: October 5th in 1998
- Renew date: September 2nd in 2015
- Google Analytics: 73184110-1
SITC Cancer Immunotherapy CONNECT - Society for Immunotherapy of Cancer (SITC)http://pageoverview.com/website-report/sitcancer.org
Cancer Immunotherapy CONNECT is the official website of the Society for Immunotherapy of Cancer (SITC), the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy.
- Expected expiration: December 13th in 2025
- Creation date: December 13th in 2010
- Renew date: January 6th in 2017
- Google Analytics: 93226076-1
- AddThis User: ra-586d5f6453e2f81d
NEW Medical Health Discoveries: AMD,Cancer, Parkinsons Disease, Alzheimer testhttp://pageoverview.com/website-report/healthdiscoveries.net
HEALTH DISCOVERIES: Today’s BEST nutrition discoveries and dietary supplements against: cancer, heart attack stroke,Parkinsons Disease, ALS, Macular Degeneration,Alzheimers,liver cancer,Lou Gehrigs
- Expected expiration: July 8th in 2018
- Creation date: July 8th in 2003
- Renew date: May 26th in 2017
- Google Analytics: 27283754-1
- Adsense ID: pub-3010335851181929
MiLaboratory.comhttp://pageoverview.com/website-report/milaboratory.com
MiLaboratory LLC develops software solutions for the deep error-free profiling of immune receptor repertoires (RepSeq) using high throughput sequencing (HTS, NGS), useful for bioinformatics - in studies of autoimmunity, vaccination, immunotherapy, hypersensitivity, checkpoint inhibitors (monoclonal antibodies), tumor infiltrating lymphocytes, T cell therapy, minimal residual disease, and adaptive immunity aging.
- Expected expiration: April 28th in 2018
- Creation date: April 28th in 2012
- Renew date: March 26th in 2017
- Google Analytics: 31409112-1
Immunotherapy for Cancer | Cancer Immunotherapy | Alternative Cancer Clinicshttp://pageoverview.com/website-report/issels.com
Immunotherapy for cancer with a focus on the tumor the microenvironment is the Issels Immuno-Oncology hallmark. As preeminent specialists in non-toxic immunotherapy and personalized cancer vaccines, we give cancer patients a chance for remission of late stage and resistant cancers.
- Expected expiration: April 9th in 2020
- Creation date: April 8th in 1997
- Renew date: August 26th in 2016
- Google Plus Account: 112163600085749916394
Home - Compass Immunology Clinichttp://pageoverview.com/website-report/immclin.com
The Compass Immunology Clinic is a specialist private medical practice providing care for patients with allergic and immunological disorders. Compass Immunology Clinic is Queensland's only comprehensive medical specialist team in Allergy and Immunology medicine.
- Expected expiration: June 10th in 2020
- Creation date: June 10th in 2012
- Renew date: April 5th in 2017
整形外科、内科をお探しなら湘南メディカル記念病院|墨田区両国駅徒歩0分http://pageoverview.com/website-report/sbc-hospital.jp
墨田区両国駅徒歩0分にある湘南メディカル記念病院では、一般外来の内科、外科、整形外科をはじめ大腸カメラ・胃カメラなど消化器専門医による検査・診断やがん免疫療法など皆様の症状・悩みに合わせた適切な医療・治療法をご提案いたします。また、予防医療としての個人健診・企業健診、長期療養するための医療療養型病床の入院設備も整っております。
- Expected expiration: February 28th in 2018
- Creation date: February 3rd in 2016
- Renew date: March 1st in 2017
- Google Analytics: 74453719-1
Nehmen Sie Ihre Gesundheit selbst in die Hand! - Best-Immunotherapy.comhttp://pageoverview.com/website-report/best-immunotherapy.com
Diese Seite führt Sie durch die fortschrittlichsten Behandlungsmethoden der Welt. Gentherapie, Immuntherapie, GcMAF Immuntherapie und Krebstherapien, GcMAF.
- Expected expiration: June 15th in 2018
- Creation date: June 15th in 2017
- Renew date: August 12th in 2017
- Google Analytics: 228838-61
- AddThis User: ra-59aead4a502e28b9
Memorial Sloan Kettering Cancer Centerhttp://pageoverview.com/website-report/mskcc.org
At MSK, cancer care – from immunotherapy and surgery to integrative medicine – is the only thing we do. Call us at 800-525-2225 or visit us at MSKCC.org to learn how we can help.
- Expected expiration: May 19th in 2020
- Creation date: May 18th in 1990
- Renew date: April 16th in 2015
ITOC - Immunotherapy of Cancer ConferenceITOChttp://pageoverview.com/website-report/itoc-conference.eu
The Immunotherapy of Cancer Conference (ITOC) is a European meeting which provides a global platform for translational research in immuno-oncology.
- Google Analytics: 51168998-1
免疫細胞療法|免疫細胞儲存|自體免疫-鑫品生醫科技股份有限公司http://pageoverview.com/website-report/vectorite.com.tw
鑫品生醫科技創立於2004年,研發團隊專注於成人健康細胞與細胞製劑製備之研究與應用,發展創新標靶免疫細胞療法(Targeted Immune Effector cell transfer immunotherapy)醫療技術及產品,治療目前束手無策之疾病,延續病患寶貴生命及改善病患生活品質。
- Creation date: May 28th in 2012
- Expected expiration: May 28th in 2019
- Google Analytics: 38325889-1
DBV Technologies | A novel technology platform called Viaskin®http://pageoverview.com/website-report/dbv-technologies.com
Clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin®
- Expected expiration: April 4th in 2018
- Creation date: April 4th in 2003
- Renew date: March 4th in 2017
NexImmune | Personalizing Cancer Treatmenthttp://pageoverview.com/website-report/neximmune.com
NexImmune is a biotech company that is rapidly advancing to clinical stage. NexImmune’s novel platform is based on the Artificial Immune AIM™ technology.
- Expected expiration: April 18th in 2018
- Creation date: April 18th in 2011
- Renew date: October 16th in 2017
子どもの鼻水・鼻づまりサイト 西宮市・芦屋市・尼崎市 梅華会グループhttp://pageoverview.com/website-report/umeoka-nasal-suction.com
梅華会グループの子どもの鼻水・鼻づまりサイトです。鼻水・鼻づまりの原因、具体的な治療法、ご家庭でもできるケアについて解説しています。
- Expected expiration: December 19th in 2017
- Creation date: December 19th in 2016
- Renew date: December 19th in 2016
- Google Analytics: 6115420-13
Anergis Ultra-Fast Allergy Immunotherapy with Long Contiguous Overlapping Peptideshttp://pageoverview.com/website-report/anergis.ch
Anergis is a clinical-stage biopharmaceutical company based near Lausanne, Switzerland. We strive to invent The Future of Allergy Treatment using our Proprietary Technology Platform to Defeat Allergies : Ultra-Fast Allergy Immunotherapy with Long Contiguous Overlapping Peptides provides Long Lasting Allergy Symptom Relief after a Single Two-Month Treatment Course. We are fully Dedicated to Research and Development in Allergy Immunotherapy.
- Google Analytics: 91031496-1
HAL Allergy Group: Homehttp://pageoverview.com/website-report/hal-allergy.com
HAL Allergy Group is active in the field of biopharmaceuticals and is located at the Bio Science Park in Leiden, The Netherlands. Our core business is the development and manufacturing of therapies and diagnostics for allergic diseases. In addition, we offer contract manufacturing services focusing on the production of biopharmaceutical products for (pre-) clinical studies. With offices in major European countries, HAL Allergy is one of the European top players in the allergy immunotherapy business. Established in 1959 HAL Allergy has long experience in developing, producing and selling allergy therapies with an immuno-modulatory effect causing a reduction in symptoms and long-term disease suppression. The allergy therapies are used against common allergies such as hay fever, house dust mites allergy and allergic reactions towards wasp or bee stings. More information is available on: http://www.hal-allergy.com. The main shareholder of HAL Allergy GmbH is Droege International Group AG, which is an independent Advisory and Investment Company, based in Düsseldorf, Germany. More information is available on: http://www.droege-group.com.
- Expected expiration: December 4th in 2017
- Creation date: December 4th in 2000
- Renew date: November 4th in 2016
- Google Analytics: 59301288-1
Southern California Allergyhttp://pageoverview.com/website-report/encinoallergy.com
Southern California Allergy specializes in the treatment of allergy, asthma and hay fever. Our Ventura Blvd office in Encino is convenient to Tarzana, Sherman Oaks and Beverly Hills.
- Expected expiration: July 7th in 2018
- Creation date: July 7th in 2011
- Renew date: May 8th in 2017
- Google Analytics: 79220341-4
Home - Cell Therapy Newshttp://pageoverview.com/website-report/celltherapynews.com
Cell Therapy News provides free weekly updates of regenerative medicine, highlighting the top cell therapy, gene therapy and immunotherapy findings.
- Expected expiration: July 30th in 2020
- Creation date: July 30th in 2001
- Renew date: April 11th in 2016
- Google Analytics: 8283745-10
耳鼻咽喉科-西宮市・芦屋市|梅華会耳鼻科グループ ネット予約可!http://pageoverview.com/website-report/umeoka-cl.com
西宮市・芦屋市の梅岡耳鼻咽喉科|世界一細い内視鏡など最新の機器を駆使して正確・迅速な診断を行います。画像や動画を使い「見えない所の病気」をどこよりも詳しく解説!安心して通えるとの声をいただいています。PC・携帯から予約可能。
- Expected expiration: July 18th in 2017
- Creation date: July 18th in 2008
- Renew date: May 27th in 2016
- Google Analytics: 6115420-1
アレルゲン免疫療法.jphttp://pageoverview.com/website-report/alg-immunotherapy.jp
鳥居薬品の『アレルゲン免疫療法.jp』は、医療に従事する方々へ、アレルゲン免疫療法(減感作療法)に関する情報を提供しています。~アレルギーを、のりこえよう、共に。~
- Expected expiration: May 31st in 2018
- Creation date: May 15th in 2015
- Renew date: June 1st in 2017
Cryoablation and Immunotherapy | Williams Cancer Institutehttp://pageoverview.com/website-report/williamscancerinstitute.com
Williams Cancer Institute specializes in cryoablation and immunotherapy practices. Talk with your doctor to see what treatment is right to treat your cancer
- Expected expiration: May 1st in 2020
- Creation date: May 1st in 2017
- Renew date: November 8th in 2017
- Google Analytics: 100128890-1
がん免疫療法(治療)なら医療法人 湘美会 湘南メディカルクリニックhttp://pageoverview.com/website-report/immunotherapy.jp
当院では自身の血液を採取してリンパ球を活性化し治療を行う副作用の少ないがん療法を行っています。免疫治療なら医療法人 湘美会 湘南メディカルクリニックへご相談ください。
- Expected expiration: March 31st in 2018
- Creation date: March 25th in 2015
- Renew date: April 1st in 2017
- Google Analytics: 33967181-2
KEYTRUDA® (pembrolizumab) | Anti–PD-1 Immunotherapyhttp://pageoverview.com/website-report/keytruda.com
Learn about how KEYTRUDA® (pembrolizumab) works to help fight certain cancers.
- Expected expiration: November 11th in 2018
- Creation date: November 11th in 2011
- Renew date: June 16th in 2014
Parker Institute for Cancer Immunotherapyhttp://pageoverview.com/website-report/parkerici.org
- Expected expiration: November 6th in 2018
- Creation date: November 6th in 2015
- Renew date: November 13th in 2016
- Google Analytics: 76169056-1
Subcutaneous Immunotherapy Treatment - STAGRAllergy.comhttp://pageoverview.com/website-report/stagrallergy.com
Subcutaneous Immunotherapy (SCIT) is available for the treatment of allergies. Learn more at STAGRAllergy.com
- Expected expiration: August 30th in 2022
- Creation date: August 30th in 2017
- Renew date: August 30th in 2017
- Google Analytics: 50398855-5
The International journal of Biological Markershttp://pageoverview.com/website-report/biological-markers.com
IJBM publishes original contributions, editorials and reviews dealing with basic and applied research in the field of biomarkers in solid tumors
- Expected expiration: April 25th in 2018
- Creation date: April 25th in 2000
- Renew date: April 10th in 2017
- Google Analytics: 1381245-7
OPDIVO® (nivolumab) | Patient Gatewayhttp://pageoverview.com/website-report/opdivo.com
OPDIVO® (nivolumab) is a prescription medication. Read about its indications, side effects, and more.
- Expected expiration: November 6th in 2017
- Creation date: November 6th in 2012
- Renew date: November 1st in 2016
ODACTRA (HDM Tablet) | ODACTRA Official Patient Website Homepagehttp://pageoverview.com/website-report/odactra.com
Official website of ODACTRA, a sublingual immunotherapy tablet for house dust mite-induced allergies, with or without conjunctivitis. Indicated for adults 18 through 65 years of age.
- Expected expiration: May 13th in 2019
- Creation date: May 13th in 2005
- Renew date: October 31st in 2017
がん治療・免疫療法なら医療法人 湘美会 湘南メディカルクリニックhttp://pageoverview.com/website-report/smc-immunotherapy.jp
自身の血液を採取してリンパ球を活性化し治療を行う副作用の少ないがん療法を行っています。免疫治療なら湘南メディカルクリニックへご相談ください。
- Expected expiration: April 30th in 2018
- Creation date: April 27th in 2016
- Renew date: May 1st in 2017
- Google Analytics: 33967181-3
Cancer Breakthroughs 2020http://pageoverview.com/website-report/cancerbreakthroughs2020.org
A historic global coalition formed to accelerate next generation immunotherapy in cancer. Learn how the Cancer Breakthroughs 2020 will address cancer care for the future.
- Google Analytics: 72863234-1
Corvus Pharmaceuticals | Immuno-oncology | Extending the reach of cancer immunotherapyhttp://pageoverview.com/website-report/corvuspharma.com
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.
- Expected expiration: February 7th in 2024
- Creation date: February 7th in 2014
- Renew date: April 17th in 2015
- Google Analytics: 61605204-1
CRI - Immunotherapy: The Answer to Cancer - Cancer Research Institutehttp://pageoverview.com/website-report/theanswertocancer.org
Immunotherapy has the potential to change how ALL cancers are treated & cured. The Cancer Research Institute is dedicated to advancing immunotherapy research.
- Expected expiration: April 3rd in 2019
- Creation date: April 3rd in 2014
- Renew date: May 14th in 2016
- Google Analytics: 3685013-1
Allergy Asthma Doctor - Long Beach & Costa Mesa CAhttp://pageoverview.com/website-report/theallergyasthma.com
Allergy asthma doctor Long Beach & Costa Mesa, CA offering Sublingual/Oral Immunotherapy treatment and Clinical trial referrals.
- Expected expiration: September 7th in 2017
- Creation date: September 7th in 2012
- Renew date: April 19th in 2017
- Google Plus Account: 104440955653647711203
Sublingual Immunotherapy | Allergy Drops | Allergychoices Inchttp://pageoverview.com/website-report/allergychoices.com
Sublingual immunotherapy with Allergychoices, La Crosse, WI, enables physicians to provide allergy sufferers information & access to allergy drops .
- Expected expiration: July 12th in 2018
- Creation date: July 12th in 2000
- Renew date: June 12th in 2017
- Google Analytics: 66240501-1
- Google Plus Account: 113057121934617133253
Allergy & Asthma Treatment in Maryland and Washington, D.C.http://pageoverview.com/website-report/premierallergist.com
The Allergy & Asthma Center provides diagnosis and treatment for children and adults with allergies and asthma. Call 1-800-778-9923 for appointment.
- Expected expiration: June 6th in 2018
- Creation date: June 6th in 2012
- Renew date: November 1st in 2017
- Google Analytics: 35126902-1
Allergopharma: allergy & specific immunotherapy specialisthttp://pageoverview.com/website-report/allergopharma.com
We are an international operating pharmaceutical company specialized in research, production and distribution of preparations for allergies.
- Expected expiration: May 10th in 2026
- Creation date: May 9th in 1997
- Renew date: June 22nd in 2017
- Google Analytics: 28614689-1
Jeannine Walstonhttp://pageoverview.com/website-report/jeanninewalston.com
Definitive, reliable education and empowerment about integrative cancer care for the whole person to improve quality of life, cancer survival, and cancer prevention.
- Expected expiration: July 31st in 2018
- Creation date: July 31st in 2012
- Renew date: July 25th in 2017
- Google Analytics: 37185424-1
- AddThis User: xa-512e54ca0fa1464b
Saisei Mirai Clinic -GcMAF-http://pageoverview.com/website-report/saisei-mirai.jp
Cancer immunotherapy clinic for complementary cancer treatment in Osaka and Kobe Japan using advanced treatments, GcMAF, Sonodynamic Photodynamic Therapy. GcMAF activates macrophages for the treatment of cancer, HIV AIDS and immune disease.
- Expected expiration: November 30th in 2018
- Creation date: November 14th in 2017
- Renew date: November 14th in 2017
Alternative & Holistic Medicine in Atlanta, Roswell, Alpharettahttp://pageoverview.com/website-report/realhealthmedical.com
Atlanta's alternative doctor/physician for functional medicine in Roswell, GA. Hormone Treatment, cancer immunotherapy, Prolozone Therapy, neurofeedback & more.
- Expected expiration: September 19th in 2018
- Creation date: September 19th in 2010
- Renew date: October 24th in 2016
- Google Analytics: 106508779-1
Keynote • Cancer clinical trials - Immunotherapyhttp://pageoverview.com/website-report/keynoteclinicaltrials.com
The Keynote Oncology Clinical Trials are studying away to treat cancer through immunotherapy. Learn more and see how you can qualify to participate.
- Expected expiration: March 11th in 2018
- Creation date: March 11th in 2015
- Renew date: July 15th in 2016
Viral wonderhttp://pageoverview.com/website-report/viralwonder.info
Poison ivy dermatitis , poison oak dermatitis, poison sumac revitol eczema cream 999 allergic contact dermatitis due to exposure to plants of the genus Rhus , which contain urushiol, a skin-sensitizing agent. People with food intolerance may have symptoms such as diarrhoea, bloating and stomach cramps. A multitude of things can cause eczema or make it worse, and they vary from person to person. In some people , eczema can also occur in the inner canal and can be extremely irritating and uncomfortable.
- Expected expiration: May 1st in 2018
- Creation date: May 1st in 2017
- Renew date: June 30th in 2017
Viralytics - Oncolytic Immunotherapyhttp://pageoverview.com/website-report/viralytics.com
- Expected expiration: October 12th in 2019
- Creation date: October 12th in 2006
- Renew date: April 27th in 2017
- Google Analytics: 23324174-1
Genomics-based diagnostics and research companyhttp://pageoverview.com/website-report/medgenome.com
Leading provider of global genomic research services and market leader for genetic diagnostic testing. Our unique access to genomics data with clinical and phenotypic information provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized healthcare. We have dedicated genomic solutions in cancer immunotherapy, diabetes and rapidly expanding into other disease areas including ophthalmology, neurology and rare diseases.
- Expected expiration: July 13th in 2019
- Creation date: July 13th in 2010
- Renew date: June 13th in 2016
- Google Analytics: 86334964-1
Vaccine & Immunotherapy Centerhttp://pageoverview.com/website-report/advancingcures.org
| Advancing cures
- Expected expiration: May 4th in 2019
- Creation date: May 4th in 2009
- Renew date: November 29th in 2016
Welcome to the Cancer Vaccine Institutehttp://pageoverview.com/website-report/icvi.org.uk
We are pioneers in researching cancer vaccines and immunotherapy to improve patients' survival rates and their quality of life for a wide range of cancers.
- Renew date: February 14th in 2018
- Google Analytics: 94036968-1
Sublingual Immunotherapy | Allergy Associates of La Crossehttp://pageoverview.com/website-report/lacrosseallergy.com
Allergy Associates of La Crosse helps you identify and treat the cause of your allergies through sublingual immunotherapy or allergy drops.
- Expected expiration: December 14th in 2018
- Creation date: December 14th in 2004
- Renew date: December 14th in 2017
- Google Analytics: 15787175-2
- Google Plus Account: +Lacrosseallergy
OPDIVO® (nivolumab) | Information for Healthcare Professionalshttp://pageoverview.com/website-report/opdivohcp.com
Learn more about OPDIVO® (nivolumab). Prescribed medication to treat certain types of cancers. Read about its indications, clinical data and efficacy.
- Expected expiration: March 3rd in 2018
- Creation date: March 3rd in 2014
- Renew date: February 27th in 2017
Home | BioTek Labshttp://pageoverview.com/website-report/bioteklabs.com
BioTek Labs is an “office within an office.” We provide you, our partners, with a new way to help your patients increase their overall health while at the same time creating an additional revenue stream for your practice. At the heart of our program is allergy testing and treatment.
- Expected expiration: June 2nd in 2021
- Creation date: June 2nd in 2011
- Renew date: August 24th in 2016
- Google Analytics: 82774341-1
HITV Lab - Welcomehttp://pageoverview.com/website-report/hitvlab.com
HITV Lab is involved in cell-based biotechnology medical applications with special focus on Dendritic Cell-Based Immunotherapy for cancer. HITV Lab is committed to support an international collaboration in the FDA clinical trial of HITV Therapy in late-stage cancer patients led by the University of Maryland, USA.
- Expected expiration: May 21st in 2019
- Creation date: May 21st in 2010
- Renew date: May 22nd in 2017
- Google Analytics: 35202363-1
Cancer Breakthroughs 2020http://pageoverview.com/website-report/cancermoonshot2020.org
A historic global coalition formed to accelerate next generation immunotherapy in cancer. Learn how the Cancer Breakthroughs 2020 will address cancer care for the future.
- Expected expiration: December 9th in 2017
- Creation date: December 9th in 2015
- Renew date: October 13th in 2016
- Google Analytics: 72863234-1
OPDIVO® (nivolumab) | Patients | Advanced Urothelial Carcinoma (Bladder Cancer)http://pageoverview.com/website-report/opdivoinformation.com
Information for consumers about OPDIVO® (nivolumab), a prescription medicine for previously treated bladder cancer (urothelial carcinoma) that has spread or grown. See Indication and Important Safety Information.
- Expected expiration: October 10th in 2018
- Creation date: October 10th in 2016
- Renew date: October 6th in 2017
BiTE® Immunotherapy: Official sitehttp://pageoverview.com/website-report/biteantibodies.com
Learn how investigational BiTE® antibodies can activate endogenous T cells to target malignant cells. Watch the proposed mechanism of BiTE® video.
- Expected expiration: October 30th in 2017
- Creation date: October 30th in 2013
- Renew date: September 28th in 2016
Journal for ImmunoTherapy of Cancer | Home pagehttp://pageoverview.com/website-report/immunotherapyofcancer.org
<p>Journal for ImmunoTherapy of Cancer, the official publication of the Society for Immunotherapy of Cancer, is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications.</p>
- Expected expiration: September 10th in 2017
- Creation date: September 10th in 2012
- Renew date: April 25th in 2016
- Google Analytics: 54492316-9
- Google Plus Account: 106226337984152901734
OPDIVO® (nivolumab) | HCP | Metastatic Urothelial Carcinoma (mUC)http://pageoverview.com/website-report/opdivoinformationhcp.com
OPDIVO® (nivolumab), for treatment of patients with previously treated locally advanced or metastatic urothelial carcinoma. See Indication and Important Safety Information.
- Expected expiration: October 10th in 2018
- Creation date: October 10th in 2016
- Renew date: October 6th in 2017
How to Survive with Multiple Food Allergies and eventually thrive againhttp://pageoverview.com/website-report/food-allergy.org
At Food-Allergy.org you will learn that there IS help for people with food allergies, even if they have IBD. By discovering and treating the rootcauses of your food allergies you can regain your health.
- Expected expiration: August 3rd in 2019
- Creation date: August 4th in 1998
- Renew date: January 16th in 2018